IBM's Watson to guide cancer therapies at 14 centers

NEW YORK, May 5 (Reuters) - Fourteen U.S. and Canadian cancer institutes will use International Business Machines Corp's Watson computer system to choose therapies based on a tumor's genetic fingerprints, the company said on Tuesday, the latest step toward bringing personalized cancer treatments to more patients.